Neurological infection with SARS-CoV-2 - the story so far

Tom Solomon, Tom Solomon

Abstract

As the COVID-19 pandemic developed and neurological manifestations were reported, concern grew that SARS-CoV-2 might directly invade neuronal cells. However, research throughout the year to address this concern has revealed a different story with inflammatory processes at its centre.

Conflict of interest statement

The author declares no competing interests

Figures

Fig. 1. Current understanding of predominant COVID-19…
Fig. 1. Current understanding of predominant COVID-19 neurological disease mechanisms.
Mechanisms include a systemic inflammatory response (1), a prothrombotic state (2) and direct viral invasion (3).

References

    1. Ellul MA, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–83. doi: 10.1016/S1474-4422(20)30221-0.
    1. Brann DH, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6:eabc5801. doi: 10.1126/sciadv.abc5801.
    1. Helms J, et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit. Care. 2020;24:491. doi: 10.1186/s13054-020-03200-1.
    1. Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754–e9. doi: 10.1212/WNL.0000000000010111.
    1. Pilotto A, Padovani A, ENCOVID-BIO Network Reply to the letter “COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation”. Ann. Neurol. 2020;88:861–862. doi: 10.1002/ana.25856.
    1. Beyrouti R, et al. Characteristics of ischaemic stroke associated with COVID-19. J. Neurol. Neurosurg. Psychiatry. 2020;91:889–891. doi: 10.1136/jnnp-2020-323586.
    1. Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919–929. doi: 10.1016/S1474-4422(20)30308-2.
    1. Paniz-Mondolfi A, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699–702. doi: 10.1002/jmv.25915.
    1. Meinhardt J, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2020 doi: 10.1038/s41593-020-00758-5.
    1. Pugin D, et al. COVID-19-related encephalopathy responsive to high-dose glucocorticoids. Neurology. 2020;95:543–546. doi: 10.1212/WNL.0000000000010354.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever